BiotechTube
Huxley Medical

Huxley Medical

Austin, United States· Est.
huxleymed.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

Huxley Medical is a private, commercial-stage company pioneering the convergence of cardiology and sleep medicine diagnostics. Its core innovation is the SANSA® system, a cellular-enabled biosensor patch and cloud platform that provides a holistic, home-based assessment for sleep apnea and comorbid cardiac arrhythmias like atrial fibrillation. With FDA clearances for both sleep apnea testing and diagnostic ECG, the company targets the significant market inefficiencies and patient backlogs in traditional, siloed diagnostic pathways. By offering a scalable, app-free solution validated against gold-standard polysomnography, Huxley positions itself as a modernizer of cardiosleep care delivery.

Sleep ApneaCardiac Arrhythmias

Technology Platform

SANSA® platform: A single-use, cellular-enabled biosensor patch that captures 9 channels of physiological data (ECG, respiratory effort, oximetry, etc.) for simultaneous sleep apnea and cardiac arrhythmia testing, paired with a cloud-based AI analytics hub (Huxley HUB™) for automated scoring and reporting.

Opportunities

The high prevalence and under-diagnosis of comorbid sleep apnea and cardiac arrhythmias present a large addressable market for an integrated solution.
The shift towards home-based diagnostics and value-based care creates a favorable environment for technologies that improve efficiency and patient access.
The platform's multimodal data capture provides a foundation for expanding into additional diagnostic and remote monitoring applications.

Risk Factors

Intense competition from established single-modality home sleep test and cardiac monitor providers.
Securing adequate and favorable reimbursement from payers for a novel, combined test is a critical hurdle.
Operational execution risks in managing a direct-to-patient device logistics and support model at scale.

Competitive Landscape

Huxley competes in the crowded home sleep testing market against giants like ResMed (SleepScore Labs, ApneaLink) and Philips (Alice NightOne), as well as pure-play HSAT companies. Its unique differentiator is the FDA-cleared integration of diagnostic-grade ECG, a feature not commonly found in HSAT devices. It also competes indirectly with traditional cardiac ambulatory monitoring companies (e.g., iRhythm, BioTelemetry) by offering arrhythmia detection in a sleep-focused form factor.

More companies in Diagnostics & Precision Medicine →More companies in United States →